In chronic myeloid leukemia cells, STAP-2 interacts with the fused BCR-ABL complex, resulting in the augmentation of its downstream signals [11]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.